Personalized Medicine Decision-Making in a Virtual Clinical Setting
-How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice.
-To study how physicians make personalized treatment decisions
-Healthy adult primary care physicians who are internal (or family) medicine residents.
- Participants will complete a screening form.
- Participants will put on a headset, called a head-mounted display, showing a virtual reality environment.
- The environment will contain an exam room and the virtual patient.
- After interacting with the virtual patient, participants will complete a series of survey measures.
- Participation will last for about 60 minutes. The virtual patient interaction and follow-up questions will be audio taped.
Deep Vein Thrombosis
|Study Design:||Observational Model: Cohort
Time Perspective: Cross-Sectional
|Official Title:||Medical Decision-Making in a Virtual Clinical Setting|
- To examine how physicians make treatment plan decisions for patients with DVT. [ Time Frame: Ongoing ]
|Study Start Date:||March 7, 2014|
|Estimated Study Completion Date:||July 31, 2018|
|Estimated Primary Completion Date:||July 31, 2017 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT02108041
|Contact: Vence L Bonham, J.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|Johns Hopkins School of Medicine||Recruiting|
|Baltimore, Maryland, United States, 21205|
|United States, Massachusetts|
|Harvard School of Public Health||Recruiting|
|Boston, Massachusetts, United States, 02115|
|United States, Michigan|
|Michigan State University||Recruiting|
|Flint, Michigan, United States|
|United States, New York|
|New York, New York, United States, 10032-3784|
|United States, Oregon|
|University of Oregon||Recruiting|
|Eugene, Oregon, United States|
|Principal Investigator:||Vence L Bonham, J.D.||National Human Genome Research Institute (NHGRI)|